SURMODICS INC (SRDX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SRDX currently has 14.3M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 0.9% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 19, 2025 |
POS AM filing: This is a Post-Effective Amendment to deregister all unsold securities from a previous registration statement due to a merger. |
14M | 0 |
| Aug 08, 2025 |
10-Q filing | 14.3M shares outstanding |
14M | 0 |
| Apr 30, 2025 |
10-Q filing | 14.3M shares outstanding |
14M | 0 |
| Jan 30, 2025 |
10-Q filing | 14.2M shares outstanding |
14M | 0 |
| Nov 20, 2024 |
10-K filing | 14.2M shares outstanding |
14M | 0 |
| Jul 31, 2024 |
10-Q filing | 14.2M shares outstanding |
14M | 0 |
| May 01, 2024 |
10-Q filing | 14.2M shares outstanding |
14M | 0 |
| Feb 01, 2024 |
10-Q filing | 14.1M shares outstanding |
14M | 0 |
| Nov 22, 2023 |
10-K filing | 14.0M shares outstanding |
14M | 0 |
| Aug 02, 2023 |
10-Q filing | 14.1M shares outstanding |
14M | 0 |
| May 12, 2023 |
S-3 filing: Surmodics, Inc. files an S-3 shelf registration to offer debt securities, preferred stock, depositary shares, common stock and securities warrants with an aggregate initial offering price of $200,000,000. |
14M | 0 |
| Apr 26, 2023 |
10-Q filing | 14.0M shares outstanding |
14M | 0 |
| Feb 06, 2023 |
10-Q filing | 14.0M shares outstanding |
14M | 0 |
| Nov 23, 2022 |
10-K filing | 13.9M shares outstanding |
14M | 0 |
| Jul 27, 2022 |
10-Q filing | 13.9M shares outstanding |
14M | 0 |
| Apr 27, 2022 |
10-Q filing | 13.9M shares outstanding |
14M | 0 |
| Feb 04, 2022 |
10-Q filing | 13.9M shares outstanding |
14M | 0 |
| Nov 24, 2021 |
10-K filing | 14.0M shares outstanding |
14M | 0 |
| Aug 04, 2021 |
10-Q filing | 13.8M shares outstanding |
14M | 0 |
| Apr 28, 2021 |
10-Q filing | 14.0M shares outstanding |
14M | 0 |
| Feb 09, 2021 |
10-Q filing | 13.7M shares outstanding |
14M | 0 |
| Dec 02, 2020 |
10-K filing | 13.6M shares outstanding |
14M | 0 |
| Aug 05, 2020 |
10-Q filing | 13.6M shares outstanding |
14M | 0 |
| May 22, 2020 |
S-3 filing: Surmodics, Inc. is filing an S-3 to register debt securities, preferred stock, depositary shares, common stock and securities warrants for a total proposed amount of $200,000,000. |
14M | 0 |
| Apr 30, 2020 |
10-Q filing | 13.5M shares outstanding |
14M | 0 |
| Feb 07, 2020 |
10-Q filing | 13.5M shares outstanding |
13M | 0 |